Loading organizations...
PatchRx is a technology company.
PatchRx developed a remote therapeutic management platform centered on a patented smart pill bottle cap, the PatchCap, designed to enhance medication adherence. This technology provides intelligent monitoring and data capture to ensure patients follow prescribed regimens, thereby improving compliance and overall health outcomes. The core offering focused on leveraging smart devices to simplify complex medication schedules for users and provide actionable insights for caregivers.
The company was co-founded in 2018 by Andrew Aertker and Gavin Buchanan, both then students at Trinity University in San Antonio. Their entrepreneurial journey began from a shared insight into the critical challenges of medication non-adherence and the potential of technology to address this pervasive healthcare issue. They sought to build a practical solution that could directly impact patient well-being through smarter engagement.
PatchRx's solution targets patients requiring consistent medication intake, enabling healthcare providers to manage and support adherence more effectively. Its vision centers on optimizing patient health by closing the loop on prescription compliance, ultimately contributing to a more effective and responsive healthcare delivery system. The company's innovations now contribute to Custom Health's broader digital health ecosystem, advancing comprehensive patient care.
PatchRx has raised $9.0M across 2 funding rounds.
PatchRx has raised $9.0M in total across 2 funding rounds.
PatchRx has raised $9.0M in total across 2 funding rounds.
PatchRx's investors include Atento Capital, Cortado Ventures, Forum Ventures, Plains Ventures, Vast Ventures, Dell Technologies Capital, Preface Ventures, Anand Babu Periasamy, Deepak Jeevan Kumar.
PatchRx is a healthcare technology company that builds a clinically backed smart-cap and software platform to measure and improve medication adherence by turning ordinary prescription vials into connected devices that deliver real‑time adherence data and patient reminders[3][4].
High‑Level Overview
Origin Story
Core Differentiators
Role in the Broader Tech Landscape
Quick Take & Future Outlook
Quick tieback: PatchRx turned a simple problem — knowing whether patients actually open their medication bottles — into a pragmatic, clinically validated hardware + software solution that attracted strategic acquisition, positioning its smart‑cap data to become a practical ingredient in larger connected‑care efforts[4][3].[4]
Sources: PatchRx company materials and product pages, Preqin profile, and the Custom Health acquisition announcement[4][2][3].[4]
PatchRx has raised $9.0M across 2 funding rounds. Most recently, it raised $8.0M Series A in August 2023.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Aug 30, 2023 | $8.0M Series A | Atento Capital | Cortado Ventures, Forum Ventures, Plains Ventures, Vast Ventures |
| Jun 1, 2021 | $1.0M Seed | Dell Technologies Capital, Preface Ventures, Anand Babu Periasamy, Deepak Jeevan Kumar |